|
⚲
|
| Keyboard |
| ImmuNovus Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002144100 |
| Sale | 2026-07-16 (5.0 M Offered, 0.8 M Sold) |
| Fund | |
| Phone | 4025478904 |
| Address | 5835 Bronco Hills Ct Denton, NE 68339 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-29 (D) |
| Exemption | 506(b) |
| Minimum | $10 |
| Remaining | $4,250,000 |
| Duration | One year or less |
| Revenue | No Revenues |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Tomas Helikar | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Orion Porfolio Solutions LLC
✚
|
NE | |
|
Karstens Investment Counsel Inc
✚
|
NE | |
|
KPM Investment Management Inc
✚
|
NE | |
|
Moylan John David
✚
|
NE | |
|
Homan Wealth Advisors LLC
✚
|
NE | |
|
Proven Ventures Burlington Capital GP LLC
✚
|
NE | |
|
Taproot Venture Partners LLC
✚
|
NE | |
|
Septumatics Inc
✚
|
NE | |
|
Macro Financial Advisors Inc
✚
|
NE | |
|
Valpar Inc
✚
|
NE |